# Adult Bipolar Mania

> **NCT00931723** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 356 (actual)

## Conditions studied

- Acute Mania

## Interventions

- **DRUG:** Quetiapine fumarate XR
- **DRUG:** Lithium
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00931723
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 356 (ACTUAL)
- **Last updated:** 2012-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00931723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00931723, "Adult Bipolar Mania". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00931723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*